Global Stereotactic Radiation Therapy Market Snapshot

The global stereotactic radiation therapy market was valued at US$ 3.7 Billion in 2022 and is expected to reach US$ 7.9 Billion by 2033. The linear accelerator radiosurgery systems with around 68.9% value share, has topped the global market within the product category in 2022 and is expected to grow at a CAGR of close to 7.3% over the forecast period (2023 to 2033)

Market Outlook:

Data Points Market Insights
Market Value 2022 US$ 3.7 Billion
Market Value 2023 US$ 3.9 Billion
Market Value 2033 US$ 7.9 Billion
CAGR 2023 to 2033 7.3%
Market Share of Top 5 Countries 62.6%
Key Market Players Mevion Medical Systems, Inc., Accuray Incorporated, MASEP Medical Science & Technology Development (Shenzhen) Co, Akesis, Inc., Elekta, Hitachi, Ltd. (Mitsubishi Electric Corporation), Siemens Healthineers AG (Varian Medical Systems, Inc.), Ion Beam Applications, ProTom International, Pronova Solutions, Sumitomo Heavy Industries, Ltd., Provision Cares, Optivus Proton Therapy Inc., Advanced Oncotherapy, Sun Nuclear Corporation, and B dot Medical Inc. (partnered with Toshiba)

The treatment of functional disorders and tiny brain tumors with stereotactic radiosurgery (SRS), a non-surgical radiation therapy has been growing rapidly. In comparison to conventional therapy, it can administer precisely focused radiation in fewer high-dose treatments, helping to maintain healthy tissue. Stereotactic body radiation (SBRT) is the name of the procedure utilised for the treatment of body tumors using SRS.

Small brain tumors and other abnormalities in function of the brain were the original target conditions for the development of stereotactic radiosurgery (SRS), a very precise radiation therapy technique. Stereotactic body radiotherapy (SBRT) is a technique used to treat body tumors that uses the same concepts as cranial SRS, namely precise radiation with delivery accuracy to within one to two millimetres.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Stereotactic Radiation Therapy Market from 2017 to 2022 Vs Market Outlook for 2023 to 2033

The global market for stereotactic radiation therapy (SRT) was around 55.3% of the overall US$ 6.6 Billion of the global radiation therapy market in 2022.

The rapid advancement of technology in the radiation therapy segment in recent years has pushed the expansion of the SRT market. The rising prevalence of cancer disorders and the growing geriatric population is driving the growing need for rapid improvement in SRT technology around the world.

The growing research for development of cost-effective stereotactic radiotherapy, and increasing awareness regarding radiotherapy are few other growth drivers increasing the demand for stereotactic radiation therapy. Globally, radiation therapy is the treatment of choice for over 7 out of 10 patients with cancers of the breast, head and neck, lung or oesophagus

There is a huge demand for radiation therapy systems in low and middle income countries as cancer kills more population than HIV, TB and malaria combines. This affects the lives of patients and their families with huge physical, emotional and financial crisis.

  • As per the insights by American Society of Clinical Oncology (ASCO)-2023, in United States, around 14 thousand men and 10 thousand women are estimated to be diagnosed with brain and spinal cord cancer in 2023. Further, more than 5 thousand children under 20 years are likely to be diagnosed with CNS tumor.

Increase in cancer cases and the sophistication of new treatment protocols drives the market for newly developed automated SRT systems which makes treatment rapid and cost-effective.

Owed to the above factors, the global market is projected to grow at CAGR of 7.3% in forecasted period.

What Factors drive the Global Market for Stereotactic Radiation Therapy Systems?

For several decades, lung cancer has been the most frequent cancer in the world.

  • According to the American Society of Clinical Oncology-2020, around 2,206,771 persons were diagnosed with lung cancer worldwide in 2020.

In a study conducted at the Markey Cancer Centre in 2021, stereotactic body radiation therapy (SBRT) was utilized for persons with stage I or stage II lung cancer who are not adequate for surgical procedure. Because X-rays are well focused and healthy tissue receives relatively little radiation, SBRT side effects are rare. This non-surgical therapy option with less side effects of the SBRT is enticing patients and clinicians to use it.

Stereotactic radiation therapy provides good tumor control rates while delivering precise doses. In comparison to conventional radiation therapy, it allows for larger radiation doses to be provided in fewer treatment sessions. This leads to better outcomes, such as higher tumor control rates and higher survival rates for some malignancies. The possibility of shorter treatment sessions and fewer side effects leads to the growing use of stereotactic radiation therapy.

Stereotactic radiation therapy is a non-invasive or minimally invasive therapeutic option that, in some situations, avoids the need for surgery. It can be used to treat both primary and metastatic tumors, offering a non-invasive alternative to invasive methods. Stereotactic radiation therapy is appealing to patients and physicians due to its ability to deliver targeted radiation without requiring open surgery.

All the above factors are expected to contribute as the driving forces for the market growth over forecast period.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining the Demand for the Stereotactic Radiation Therapy?

Moving targets, such as tumors impacted by respiration or other physiological motion, can be difficult to target and track accurately in stereotactic radiation therapy. Techniques such as respiratory gating or tumor tracking may be used to solve this issue, but they complicate the treatment process and necessitate more resources.

Stereotactic radiation therapy necessitates extensive technical knowledge and specialised training. SRT's success is dependent on accurate treatment planning, target localization, and precision radiation delivery. Because of the complexities of the therapy procedure, trained radiation oncologists, medical physicists, and dosimetrists are required, which can be a constraint in some circumstances.

While stereotactic radiation therapy has demonstrated excellent short-term outcomes, there is a need for more long-term data on its effectiveness and potential late toxicities. Long-term follow-up studies are essential to evaluate the durability of tumor control and the impact on patient survival and quality of life. The limited availability of long-term data may influence decision-making and adoption of SRT in certain scenarios.

Country-wise Insights

Why is U.S. a Prominent Market for Stereotactic Radiation Therapy in North America Region?

The U.S. occupies 33.7% of market share in 2022 globally. The growing prevalence of cancer and the need for effective treatment choices drive the demand for sophisticated radiation therapy techniques like stereotactic radiation therapy. As the incidence of cancer rises, so does the demand for precise and focused therapies such as stereotactic radiation therapy.

  • According to the American Cancer Society, 1.9 million additional cancer cases are projected in the United States in 2023.

These factors, together with continuous research and clinical trials, continue to promote stereotactic radiation therapy's adoption and development as a key treatment technique in oncology and other medical sectors.

What Makes China a Highly Lucrative Market for Stereotactic Radiation Therapy?

China expenditure on stereotactic radiation therapy in 2022 was US$ 272.8 Million.

China approaches healthcare collaboratively, with substantial relationships between hospitals, research institutions, and industrial players.

  • For example, in March 2023, China National Pharmaceutical firm Corp (Sinopharm), a State-owned healthcare firm, announced a joint venture deal with Elekta, a Swedish medical equipment manufacturer, to manufacture radiation equipment in China.

Ongoing SRT research and clinical trials help to enhance the evidence base and improve treatment methods. The good findings of these research are driving the use of SRT in clinical practise.

What Makes the Germany a Large Market for Stereotactic Radiation Therapy?

In 2022, the Germany held a significant share in the global market and contributed around US$ 318.1 Million. Germany has a well-developed healthcare system that includes cutting-edge medical facilities, hospitals, and research institutes. The availability of cutting-edge radiation treatment equipment and expertise facilitates the country's extensive adoption of SRT. Germany lays a great emphasis on providing patients with least invasive treatment choices. SRT is an outpatient, non-invasive technique that delivers very precise radiation to tumors, minimising the need for open surgery. The demand for non-invasive treatments corresponds to the expansion of the SRT market in Germany.

Germany is well-known for its medical technical breakthroughs. SRT has become more precise and effective as better imaging devices, treatment planning software, and real-time tumor tracking technologies have been developed and adopted. These technical improvements aid in the expansion of the SRT market in Germany.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which Technology is Predicted to Expand Rapidly Between 2023 and 2033?

By technology, linear accelerator radiosurgery systems held 68.9% market share in world in 2022.

A linear accelerator radiation therapy tailors high-energy radiation such as x-rays or electrons to conform to the contour of a tumor to damage cancer cells while preserving normal tissue in the surrounding area. It has numerous built-in safety safeguards to ensure that it delivers the correct dose and is frequently examined by a medical physicist to confirm that it is functioning properly. This precise treatment use of technology is helping these therapies gain popularity.

Why Molecular Weight is Preferred Prominently in Stereotactic Radiation Therapy?

CNS cancer held 24.5% market share in 2022 globally.

SRS reduces the risk of haemorrhage, infection, and anaesthesia associated with surgery. It is an outpatient procedure that involves little interruption of other therapies, like as chemotherapy. The outcomes of SRS for brain metastases or other CNS malignancies appear to be comparable to those of surgery to remove the tumor. This is the rationale for the widespread use of these technologies in CNS cancer treatment around the world.

Which End User is Benefiting the Global Market?

The hospitals have a considerable presence in the stereotactic radiation therapy market, accounting for 42.2% value share in 2022, and exhibit a high CAGR of 6.2% over the forecast period. The increased use of SRT in hospitals is a result of more data generated during cancer diagnosis and treatment, as well as increased patient visits globally each year. Increasing government initiatives aimed at providing hospitals with cutting-edge technology are a few of the factors driving this market's expansion.

Competitive Landscape

Collaboration in research & development, and commercialization to expand market and create technologically advanced systems with new-edge applications are key strategies adopted by key players. Numerous large firms compete in the field of stereotactic radiation therapy. Among the well-known players in this field are:

  • Oct. 2022, The MEVION S250-FIT Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) has been introduced by Mevion Medical Systems. The technology will be designed and installed for the first time at Stanford Health Care.
  • May 2023, At the ESTRO convention in Vienna, Austria, from May 12 to 16, 2023, Varian, a Siemens Healthineers company, will highlight its comprehensive cancer care solutions, which include cutting-edge imaging, radiation therapy, software, and services.

Similarly, recent developments related to the company’s manufacturing the stereotactic radiation therapy systems have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as Per Stereotactic Radiation Therapy Industry Analysis

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis US$ Million for Value, Units for Volume
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA)
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, Nordics, China, Japan, South Korea, India, Indonesia, Thailand, Philippines, Vietnam, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Israel, Northern Africa and South Africa.
Key Market Segments Covered Technology, Indication, End User, and Region
Key Companies Profiled
  • Mevion Medical Systems, Inc.
  • Hitachi, Ltd. (Mitsubishi Electric Corporation)
  • Accuray Incorporated
  • MASEP Medical Science & Technology Development (Shenzhen) Co
  • Akesis, Inc
  • Elekta
  • Siemens Healthineers AG (Varian Medical Systems, Inc.)
  • Ion Beam Applications
  • ProTom International
  • Pronova Solutions
  • Sumitomo Heavy Industries, Ltd.
  • Provision Cares
  • Optivus Proton Therapy Inc.
  • Advanced Oncotherapy
  • Sun Nuclear Corporation
  • B dot Medical Inc. (partnered with Toshiba)
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Pricing Available upon Request

Key Market Segments Covered in the Stereotactic Radiation Therapy Industry Research

By Technology:

  • Linear Accelerator Radiosurgery Systems
  • GammaKnife Radiosurgery Systems
  • Proton Beam Therapy
  • CyberKnife

By Indication:

  • CNS Cancer
  • Prostate Cancer
  • Head and Neck
  • Breast Cancer
  • Lung Cancer
  • Other

By End User:

  • Hospitals
  • Imaging Centers
  • Cancer Research Centers
  • Oncological Treatment Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

What is the Market Size in 2023?

The market is valued at US$ 3.9 billion in 2023.

What is the Market Growth Outlook?

The market is likely to register a CAGR of 7.3% from 2023 to 2033.

How Big will be the Market in 2033?

The market is projected to value at US$ 7.9 billion in 2033.

What is the Market Share of the Top 5 Countries?

The market share of the top 5 countries is 62.6%.

What Opportunities Await the Market Players?

Technological advancements in radiation therapy are likely to provide a boost to the market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions & Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Value Added Insights

    4.1. Product Adoption / Usage Analysis

    4.2. Installed Base Scenario

    4.3. Disease Epidemiology by Key Indications

    4.4. Technology Assessment

    4.5. Regulatory Scenario

    4.6. Reimbursement Landscape

    4.7. PESTLE Analysis

    4.8. Porter’s Analysis

    4.9. Value Chain Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global Healthcare Expenditure

        5.1.2. Global Life Expectancy Outlook

        5.1.3. Global Radiation Therapy Market Overview

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Top Companies Historical Growth

        5.2.2. Technological Advancements in Stereotactic Radiation Therapy

        5.2.3. New Product Launches

        5.2.4. Ease of Treatment in Outpatient Basis

        5.2.5. Improved Access to Healthcare Services

        5.2.6. Increasing Minimally Invasive Treatment Options

        5.2.7. Cost of Products

        5.2.8. Increasing Prevalence of Cancer

        5.2.9. Favorable Policies by Government

        5.2.10. Strategic Mergers and Acquisitions among Players

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Market Demand Volume Analysis 2017 –2022 and Forecast, 2023 to 2033

    6.1. Historical Market Volume (Units) Analysis, 2017 –2022

    6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market - Pricing Analysis

    7.1. Regional Pricing Analysis, By-Product

    7.2. Pricing Break Up

        7.2.1. Manufacturer Level

        7.2.2. Distributor Level

    7.3. Global Average Pricing Analysis Benchmark

    7.4. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033

    8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022

    8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Technology

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Technology, 2017 to 2022

    9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Technology, 2023 to 2033

        9.3.1. Linear Accelerator Radiosurgery Systems

        9.3.2. GammaKnife Radiosurgery Systems

        9.3.3. Proton Beam Therapy

        9.3.4. CyberKnife

    9.4. Market Attractiveness Analysis, By Technology

10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Indication, 2017 to 2022

    10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Indication, 2023 to 2033

        10.3.1. CNS Cancer

        10.3.2. Prostate Cancer

        10.3.3. Head and Neck

        10.3.4. Breast Cancer

        10.3.5. Lung Cancer

        10.3.6. Other

    10.4. Market Attractiveness Analysis, By Indication

11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis, By End User, 2017 to 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By End User, 2023 to 2033

        11.3.1. Hospitals

        11.3.2. Imaging Centers

        11.3.3. Cancer Research Centers

        11.3.4. Oncological Treatment Centers

    11.4. Market Attractiveness Analysis, By End User

12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Region, 2017 to 2022

    12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Region, 2023 to 2033

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa (Middle East & Africa)

    12.4. Market Attractiveness Analysis, By Region

13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    13.1. Introduction

    13.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2017 to 2022

    13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        13.3.1. By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Technology

        13.3.3. By Indication

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Technology

        13.4.3. By Indication

        13.4.4. By End User

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

    13.7. Market Trends

    13.8. Country Level Analysis & Forecast

        13.8.1. U.S. Market

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast, By Market Taxonomy

                13.8.1.2.1. By Technology

                13.8.1.2.2. By Indication

                13.8.1.2.3. By End User

        13.8.2. Canada Market

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast, By Market Taxonomy

                13.8.2.2.1. By Technology

                13.8.2.2.2. By Indication

                13.8.2.2.3. By End User

14. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2017 to 2022

    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Technology

        14.3.3. By Indication

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Technology

        14.4.3. By Indication

        14.4.4. By End User

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

    14.7. Market Trends

    14.8. Country Level Analysis & Forecast

        14.8.1. Brazil Market

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast, By Market Taxonomy

                14.8.1.2.1. By Technology

                14.8.1.2.2. By Indication

                14.8.1.2.3. By End User

        14.8.2. Argentina Market

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast, By Market Taxonomy

                14.8.2.2.1. By Technology

                14.8.2.2.2. By Indication

                14.8.2.2.3. By End User

        14.8.3. Mexico Market

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast, By Market Taxonomy

                14.8.3.2.1. By Technology

                14.8.3.2.2. By Indication

                14.8.3.2.3. By End User

15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2017 to 2022

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Nordic Countries

            15.3.1.8. Russia

            15.3.1.9. Rest of Europe

        15.3.2. By Technology

        15.3.3. By Indication

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Technology

        15.4.3. By Indication

        15.4.4. By End User

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

    15.7. Market Trends

    15.8. Country Level Analysis & Forecast

        15.8.1. Germany Market

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast, By Market Taxonomy

                15.8.1.2.1. By Technology

                15.8.1.2.2. By Indication

                15.8.1.2.3. By End User

        15.8.2. France Market

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast, By Market Taxonomy

                15.8.2.2.1. By Technology

                15.8.2.2.2. By Indication

                15.8.2.2.3. By End User

        15.8.3. Italy Market

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast, By Market Taxonomy

                15.8.3.2.1. By Technology

                15.8.3.2.2. By Indication

                15.8.3.2.3. By End User

        15.8.4. Spain Market

            15.8.4.1. Introduction

            15.8.4.2. Market Analysis and Forecast, By Market Taxonomy

                15.8.4.2.1. By Technology

                15.8.4.2.2. By Indication

                15.8.4.2.3. By End User

        15.8.5. U.K. Market

            15.8.5.1. Introduction

            15.8.5.2. Market Analysis and Forecast, By Market Taxonomy

                15.8.5.2.1. By Technology

                15.8.5.2.2. By Indication

                15.8.5.2.3. By End User

        15.8.6. BENELUX Market

            15.8.6.1. Introduction

            15.8.6.2. Market Analysis and Forecast, By Market Taxonomy

                15.8.6.2.1. By Technology

                15.8.6.2.2. By Indication

                15.8.6.2.3. By End User

        15.8.7. Nordic Countries Market

            15.8.7.1. Introduction

            15.8.7.2. Market Analysis and Forecast, By Market Taxonomy

                15.8.7.2.1. By Technology

                15.8.7.2.2. By Indication

                15.8.7.2.3. By End User

        15.8.8. Russia Market

            15.8.8.1. Introduction

            15.8.8.2. Market Analysis and Forecast, By Market Taxonomy

                15.8.8.2.1. By Technology

                15.8.8.2.2. By Indication

                15.8.8.2.3. By End User

16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2017 to 2022

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Vietnam

            16.3.1.6. Philippines

            16.3.1.7. Rest of South Asia

        16.3.2. By Technology

        16.3.3. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Technology

        16.4.3. By Indication

        16.4.4. By End User

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

    16.7. Market Trends

    16.8. Country Level Analysis & Forecast

        16.8.1. India Market

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast, By Market Taxonomy

                16.8.1.2.1. By Technology

                16.8.1.2.2. By Indication

                16.8.1.2.3. By End User

        16.8.2. Indonesia Market

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast, By Market Taxonomy

                16.8.2.2.1. By Technology

                16.8.2.2.2. By Indication

                16.8.2.2.3. By End User

        16.8.3. Malaysia Market

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast, By Market Taxonomy

                16.8.3.2.1. By Technology

                16.8.3.2.2. By Indication

                16.8.3.2.3. By End User

        16.8.4. Thailand Market

            16.8.4.1. Introduction

            16.8.4.2. Market Analysis and Forecast, By Market Taxonomy

                16.8.4.2.1. By Technology

                16.8.4.2.2. By Indication

                16.8.4.2.3. By End User

        16.8.5. Vietnam Market

            16.8.5.1. Introduction

            16.8.5.2. Market Analysis and Forecast, By Market Taxonomy

                16.8.5.2.1. By Technology

                16.8.5.2.2. By Indication

                16.8.5.2.3. By End User

        16.8.6. Philippines Market

            16.8.6.1. Introduction

            16.8.6.2. Market Analysis and Forecast, By Market Taxonomy

                16.8.6.2.1. By Technology

                16.8.6.2.2. By Indication

                16.8.6.2.3. By End User

17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2017 to 2022

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Technology

        17.3.3. By Indication

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Technology

        17.4.3. By Indication

        17.4.4. By End User

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

    17.7. Market Trends

    17.8. Country Level Analysis & Forecast

        17.8.1. China Market

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast, By Market Taxonomy

                17.8.1.2.1. By Technology

                17.8.1.2.2. By Indication

                17.8.1.2.3. By End User

        17.8.2. Japan Market

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast, By Market Taxonomy

                17.8.2.2.1. By Technology

                17.8.2.2.2. By Indication

                17.8.2.2.3. By End User

        17.8.3. South Korea Market

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast, By Market Taxonomy

                17.8.3.2.1. By Technology

                17.8.3.2.2. By Indication

                17.8.3.2.3. By End User

18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2017 to 2022

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Technology

        18.3.3. By Indication

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Technology

        18.4.3. By Indication

        18.4.4. By End User

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

    18.7. Market Trends

    18.8. Country Level Analysis & Forecast

        18.8.1. Australia Market

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast, By Market Taxonomy

                18.8.1.2.1. By Technology

                18.8.1.2.2. By Indication

                18.8.1.2.3. By End User

        18.8.2. New Zealand Market

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast, By Market Taxonomy

                18.8.2.2.1. By Technology

                18.8.2.2.2. By Indication

                18.8.2.2.3. By End User

19. Middle East and Africa (Middle East & Africa) Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2017 to 2022

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Israel

            19.3.1.3. Türkiye

            19.3.1.4. Northern Africa

            19.3.1.5. South Africa

            19.3.1.6. Rest of Middle East and Africa

        19.3.2. By Technology

        19.3.3. By Indication

        19.3.4. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Technology

        19.4.3. By Indication

        19.4.4. By End User

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

    19.7. Market Trends

    19.8. Country Level Analysis & Forecast

        19.8.1. GCC Countries Market

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast, By Market Taxonomy

                19.8.1.2.1. By Technology

                19.8.1.2.2. By Indication

                19.8.1.2.3. By End User

        19.8.2. Israel Market

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast, By Market Taxonomy

                19.8.2.2.1. By Technology

                19.8.2.2.2. By Indication

                19.8.2.2.3. By End User

        19.8.3. Türkiye Market

            19.8.3.1. Introduction

            19.8.3.2. Market Analysis and Forecast, By Market Taxonomy

                19.8.3.2.1. By Technology

                19.8.3.2.2. By Indication

                19.8.3.2.3. By End User

        19.8.4. Northern Africa Market

            19.8.4.1. Introduction

            19.8.4.2. Market Analysis and Forecast, By Market Taxonomy

                19.8.4.2.1. By Technology

                19.8.4.2.2. By Indication

                19.8.4.2.3. By End User

        19.8.5. South Africa Market

            19.8.5.1. Introduction

            19.8.5.2. Market Analysis and Forecast, By Market Taxonomy

                19.8.5.2.1. By Technology

                19.8.5.2.2. By Indication

                19.8.5.2.3. By End User

20. Market Structure Analysis

    20.1. Market Analysis, By Tier of Companies

    20.2. Market Share Analysis of Top Players

    20.3. Market Concentration

    20.4. Market Presence Analysis

        20.4.1. Regional Footprint Analysis

        20.4.2. Product Footprint Analysis

        20.4.3. Channel Footprint Analysis

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Branding and Promotional Strategies, By Key Players

    21.3. Key Development Analysis

    21.4. Competition Deep Dive

        21.4.1. Mevion Medical Systems, Inc.

            21.4.1.1. Overview

            21.4.1.2. Product Portfolio

            21.4.1.3. Key Financials

            21.4.1.4. SWOT Analysis

            21.4.1.5. Sales Footprint

            21.4.1.6. Strategy Overview

            21.4.1.7. Key Developments

                21.4.1.7.1. Marketing Strategies

                21.4.1.7.2. Product Strategies

                21.4.1.7.3. Channel Strategies

        21.4.2. Accuray Incorporated

            21.4.2.1. Overview

            21.4.2.2. Product Portfolio

            21.4.2.3. Key Financials

            21.4.2.4. SWOT Analysis

            21.4.2.5. Sales Footprint

            21.4.2.6. Strategy Overview

            21.4.2.7. Key Developments

                21.4.2.7.1. Marketing Strategies

                21.4.2.7.2. Product Strategies

                21.4.2.7.3. Channel Strategies

        21.4.3. MASEP Medical Science & Technology Development (Shenzhen) Co

            21.4.3.1. Overview

            21.4.3.2. Product Portfolio

            21.4.3.3. Key Financials

            21.4.3.4. SWOT Analysis

            21.4.3.5. Sales Footprint

            21.4.3.6. Strategy Overview

            21.4.3.7. Key Developments

                21.4.3.7.1. Marketing Strategies

                21.4.3.7.2. Product Strategies

                21.4.3.7.3. Channel Strategies

        21.4.4. Akesis, Inc

            21.4.4.1. Overview

            21.4.4.2. Product Portfolio

            21.4.4.3. Key Financials

            21.4.4.4. SWOT Analysis

            21.4.4.5. Sales Footprint

            21.4.4.6. Strategy Overview

            21.4.4.7. Key Developments

                21.4.4.7.1. Marketing Strategies

                21.4.4.7.2. Product Strategies

                21.4.4.7.3. Channel Strategies

        21.4.5. Elekta

            21.4.5.1. Overview

            21.4.5.2. Product Portfolio

            21.4.5.3. Key Financials

            21.4.5.4. SWOT Analysis

            21.4.5.5. Sales Footprint

            21.4.5.6. Strategy Overview

            21.4.5.7. Key Developments

                21.4.5.7.1. Marketing Strategies

                21.4.5.7.2. Product Strategies

                21.4.5.7.3. Channel Strategies

        21.4.6. Hitachi, Ltd. (Mitsubishi Electric Corporation)

            21.4.6.1. Overview

            21.4.6.2. Product Portfolio

            21.4.6.3. Key Financials

            21.4.6.4. SWOT Analysis

            21.4.6.5. Sales Footprint

            21.4.6.6. Strategy Overview

            21.4.6.7. Key Developments

                21.4.6.7.1. Marketing Strategies

                21.4.6.7.2. Product Strategies

                21.4.6.7.3. Channel Strategies

        21.4.7. Siemens Healthineers AG (Varian Medical Systems, Inc.)

            21.4.7.1. Overview

            21.4.7.2. Product Portfolio

            21.4.7.3. Key Financials

            21.4.7.4. SWOT Analysis

            21.4.7.5. Sales Footprint

            21.4.7.6. Strategy Overview

            21.4.7.7. Key Developments

                21.4.7.7.1. Marketing Strategies

                21.4.7.7.2. Product Strategies

                21.4.7.7.3. Channel Strategies

        21.4.8. Ion Beam Applications

            21.4.8.1. Overview

            21.4.8.2. Product Portfolio

            21.4.8.3. Key Financials

            21.4.8.4. SWOT Analysis

            21.4.8.5. Sales Footprint

            21.4.8.6. Strategy Overview

            21.4.8.7. Key Developments

                21.4.8.7.1. Marketing Strategies

                21.4.8.7.2. Product Strategies

                21.4.8.7.3. Channel Strategies

        21.4.9. ProTom International

            21.4.9.1. Overview

            21.4.9.2. Product Portfolio

            21.4.9.3. Key Financials

            21.4.9.4. SWOT Analysis

            21.4.9.5. Sales Footprint

            21.4.9.6. Strategy Overview

            21.4.9.7. Key Developments

                21.4.9.7.1. Marketing Strategies

                21.4.9.7.2. Product Strategies

                21.4.9.7.3. Channel Strategies

        21.4.10. Pronova Solutions

            21.4.10.1. Overview

            21.4.10.2. Product Portfolio

            21.4.10.3. Key Financials

            21.4.10.4. SWOT Analysis

            21.4.10.5. Sales Footprint

            21.4.10.6. Strategy Overview

            21.4.10.7. Key Developments

                21.4.10.7.1. Marketing Strategies

                21.4.10.7.2. Product Strategies

                21.4.10.7.3. Channel Strategies

        21.4.11. Sumitomo Heavy Industries, Ltd.

            21.4.11.1. Overview

            21.4.11.2. Product Portfolio

            21.4.11.3. Key Financials

            21.4.11.4. SWOT Analysis

            21.4.11.5. Sales Footprint

            21.4.11.6. Strategy Overview

            21.4.11.7. Key Developments

                21.4.11.7.1. Marketing Strategies

                21.4.11.7.2. Product Strategies

                21.4.11.7.3. Channel Strategies

        21.4.12. Provision Cares

            21.4.12.1. Overview

            21.4.12.2. Product Portfolio

            21.4.12.3. Key Financials

            21.4.12.4. SWOT Analysis

            21.4.12.5. Sales Footprint

            21.4.12.6. Strategy Overview

            21.4.12.7. Key Developments

                21.4.12.7.1. Marketing Strategies

                21.4.12.7.2. Product Strategies

                21.4.12.7.3. Channel Strategies

        21.4.13. Optivus Proton Therapy Inc.

            21.4.13.1. Overview

            21.4.13.2. Product Portfolio

            21.4.13.3. Key Financials

            21.4.13.4. SWOT Analysis

            21.4.13.5. Sales Footprint

            21.4.13.6. Strategy Overview

            21.4.13.7. Key Developments

                21.4.13.7.1. Marketing Strategies

                21.4.13.7.2. Product Strategies

                21.4.13.7.3. Channel Strategies

        21.4.14. Advanced Oncotherapy

            21.4.14.1. Overview

            21.4.14.2. Product Portfolio

            21.4.14.3. Key Financials

            21.4.14.4. SWOT Analysis

            21.4.14.5. Sales Footprint

            21.4.14.6. Strategy Overview

            21.4.14.7. Key Developments

                21.4.14.7.1. Marketing Strategies

                21.4.14.7.2. Product Strategies

                21.4.14.7.3. Channel Strategies

        21.4.15. Sun Nuclear Corporation

            21.4.15.1. Overview

            21.4.15.2. Product Portfolio

            21.4.15.3. Key Financials

            21.4.15.4. SWOT Analysis

            21.4.15.5. Sales Footprint

            21.4.15.6. Strategy Overview

            21.4.15.7. Key Developments

                21.4.15.7.1. Marketing Strategies

                21.4.15.7.2. Product Strategies

                21.4.15.7.3. Channel Strategies

        21.4.16. B dot Medical Inc. (partnered with Toshiba)

            21.4.16.1. Overview

            21.4.16.2. Product Portfolio

            21.4.16.3. Key Financials

            21.4.16.4. SWOT Analysis

            21.4.16.5. Sales Footprint

            21.4.16.6. Strategy Overview

            21.4.16.7. Key Developments

                21.4.16.7.1. Marketing Strategies

                21.4.16.7.2. Product Strategies

                21.4.16.7.3. Channel Strategies

22. Assumptions and Acronyms Used

23. Research Methodology

Recommendations

Healthcare

Single Dose Radiotherapy Services Market

March 2021

REP-GB-13033

June 2023

244 pages

Healthcare

Radiation Therapy Software Market

June 2017

REP-GB-4093

August 2022

333 pages

Healthcare

Radiation-Induced Myelosuppression Treatment Market

January 2022

REP-GB-8116

July 2022

207 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Stereotactic Radiation Therapy Market